24 results
DEF 14A
CHRO
Chromocell Therapeutics Corp
26 Sep 24
Definitive proxy
5:08pm
GOVERNANCE
Board of Directors
Director Independence
Board Meetings and Attendance
Annual Meeting Attendance
Stockholder Communications with the Board … of their earlier resignation or removal, or if for some other reason they are unable to serve in the capacity of director.
Director Independence
The Board consists
PRE 14A
CHRO
Chromocell Therapeutics Corp
9 Sep 24
Preliminary proxy
5:30pm
and Recommendation
CORPORATE GOVERNANCE
Board of Directors
Director Independence
Board Meetings and Attendance
Annual Meeting Attendance … , or if for some other reason they are unable to serve in the capacity of director.
Director Independence
The Board consists of five members. The number
424B3
CHRO
Chromocell Therapeutics Corp
29 Jul 24
Prospectus supplement
9:08am
of the auditor independence requirements of SOXA with respect to the Company.
(vi) There is, and during the past twelve (12) months there has been, no failure … and the Public Company Accounting Oversight Board (United States). To the Company’s Knowledge, the Accountant is not in violation of the auditor independence
424B3
CHRO
Chromocell Therapeutics Corp
29 Jul 24
Prospectus supplement
9:07am
independence requirements of SOXA with respect to the Company.
(vi) There is, and during the past twelve (12) months there has been, no failure … and the Public Company Accounting Oversight Board (United States). To the Company’s Knowledge, the Accountant is not in violation of the auditor independence
8-K
EX-10.1
CHRO
Chromocell Therapeutics Corp
29 Jul 24
Entry into a Material Definitive Agreement
9:06am
is not in violation of the auditor independence requirements of SOXA with respect to the Company.
(vi) There is, and during the past twelve (12) months there has been
8-K
EX-10.2
0yt4 438feuftq30hkms
29 Jul 24
Entry into a Material Definitive Agreement
9:06am
424B3
9xbuhdh
16 Apr 24
Prospectus supplement
5:49pm
424B3
ruf8zj8e1b
16 Apr 24
Prospectus supplement
5:45pm
10-K
vli26t7g2ih10extk7rj
16 Apr 24
Annual report
4:48pm
8-K
EX-3.2
65vd1vd 27
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
7mn0i01ooj8xxek mi9g
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
bpowa jhc8b
20 Feb 24
Prospectus supplement with pricing info
5:28pm